2025-05-02 11:12:14
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Bafna Pharmaceuticals Q3FY22 net profit at Rs. 1.70 crore
Posted On : 2022-02-10 21:11:46( TIMEZONE : IST )
Bafna Pharmaceuticals Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 20.9473 crores during the period ended December 31, 2021 as compared to Rs. 28.6156 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.7028 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 2.3763 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.72 for the period ended December 31, 2021 as compared to Rs. 0.95 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹20.9473 crs | ₹28.6156 crs |  -26.80% |
| Net Profit | ₹1.7028 crs | ₹2.3763 crs | -28.34% |
| EPS | ₹0.72 | ₹0.95 | -24.21% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs.20.9473 crores during the period ended December 31, 2021 as compared to Rs.17.5144 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.7028 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.9004 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.72 for the period ended December 31, 2021 as compared to Rs.0.38 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹20.9473 crs | ₹17.5144 crs |  19.60% |
| Net Profit | ₹1.7028 crs | ₹0.9004 crs | 89.12% |
| EPS | ₹0.72 | ₹0.38 | 89.47% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.70.9916 crores during the 9 Months period ended December 31, 2021 as compared to Rs.49.8192 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.6.1661 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.3.1907 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.2.55 for the 9 Months period ended December 31, 2021 as compared to Rs.1.35 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹70.9916 crs | ₹49.8192 crs | 42.50% |
| Net Profit | ₹6.1661 crs | ₹3.1907 crs | 93.25% |
| EPS | ₹2.55 | ₹1.35 | 88.89% |
Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 179.50 as compared to the previous close of Rs. 174.20. The total number of shares traded during the day was 6659 in over 257 trades.
The stock hit an intraday high of Rs. 190.70 and intraday low of 174.00. The net turnover during the day was Rs. 1193991.00.
